Mirum Pharmaceuticals Inc.
MIRM | NASDAQ
$92
+$0.17 (+0.19%)
At close: Sep 21, 2026, 4:00 PM ET
$92.50
+$0.50 (+0.54%)
Pre-market:
Sep 22, 2026, 8:00 AM ET
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 618.07M | 569.61M | 521.31M | 471.79M | 429.16M | 379.25M | 336.89M | 307.03M | 264.38M | 224M | 186.37M | 144.73M | 115.78M | 95.77M | 77.06M | 52.29M | 38.51M | 32.03M | 19.14M | 16M | 11M | n/a |
Cost of Revenue | 113.1M | 106.18M | 100.31M | 94.76M | 90.03M | 86.83M | 81.64M | 83.88M | 73.31M | 59.89M | 47.04M | 26.51M | 19.22M | 14.93M | 12.37M | 9.78M | 6.85M | 4.33M | 1.9M | n/a | n/a | n/a |
Gross Profit | 504.96M | 463.43M | 421M | 377.04M | 339.14M | 292.42M | 255.25M | 223.15M | 191.07M | 164.11M | 139.34M | 118.21M | 96.56M | 80.84M | 64.69M | 42.51M | 31.66M | 27.7M | 17.24M | 16M | 11M | n/a |
Operating Income | -107.66M | -70.12M | -22.14M | -41.79M | -57.08M | -76.32M | -87.61M | -95.97M | -108.43M | -108.47M | -109.15M | -110.73M | -118.46M | -125.63M | -131.22M | -142.63M | -152.58M | -158.54M | -173.41M | -164.79M | -143.68M | -129.88M |
Interest Income | 13.92M | 13.11M | 12.73M | 12.51M | 12.73M | 13.18M | 13.79M | 14.36M | 14.96M | 15.1M | 13.74M | 12.1M | 9.39M | 6.06M | 3.86M | 1.78M | 499K | 286K | 366K | 469K | 634K | 959K |
Pretax Income | -857.54M | -797.46M | -21.43M | -40.83M | -57.36M | -75.91M | -86.91M | -97.98M | -107.43M | -157.15M | -162.42M | -163.28M | -175.64M | -135.41M | -142.07M | -48.22M | -59.63M | -70.02M | -83.95M | -178.71M | -153.12M | -132.49M |
Net Income | -860.21M | -798.84M | -23.36M | -41.42M | -58.56M | -77.34M | -87.94M | -99.81M | -109.16M | -158.56M | -163.42M | -164.19M | -176.31M | -129.19M | -135.67M | -41.69M | -53.09M | -70.06M | -83.99M | -178.74M | -153.14M | -132.49M |
Selling & General & Admin | 313.84M | 295.65M | 257.03M | 239.73M | 228.37M | 214.29M | 202.22M | 191.58M | 177.56M | 161.3M | 145.88M | 126.16M | 112.15M | 100.17M | 89.07M | 81.63M | 76.47M | 68.86M | 59.22M | 47.41M | 35.79M | 27.48M |
Research & Development | 282.51M | 238.04M | 186.18M | 179.1M | 167.85M | 154.45M | 140.63M | 127.54M | 121.95M | 111.28M | 102.61M | 102.78M | 102.88M | 106.3M | 106.84M | 103.51M | 107.77M | 117.38M | 131.43M | 133.38M | 118.89M | 102.4M |
Other Expenses | 16.44M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 612.78M | 533.7M | 443.21M | 418.83M | 396.21M | 368.74M | 342.85M | 319.11M | 299.5M | 272.58M | 248.49M | 228.94M | 215.03M | 206.47M | 195.91M | 185.15M | 184.24M | 186.24M | 190.65M | 180.79M | 154.68M | 129.88M |
Interest Expense | 13.44M | 14.41M | 14.39M | 14.37M | 14.35M | 14.33M | 14.31M | 14.3M | 14.28M | 14.44M | 15.11M | 15.9M | 16.3M | 16.45M | 15.98M | 15.39M | 17.08M | 17.98M | 17.59M | 14.16M | 8.49M | 3.72M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | 7.97M | 7.97M | 7.97M | 7.97M | n/a | n/a | 9.51M | 9.51M | 9.51M | 9.51M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 725.73M | 639.73M | 543.45M | 513.59M | 486.24M | 455.57M | 424.49M | 403M | 372.81M | 332.47M | 295.53M | 255.46M | 234.25M | 221.4M | 208.28M | 194.93M | 191.09M | 190.57M | 192.55M | 180.79M | 154.68M | 129.88M |
Income Tax Expense | 2.67M | 1.38M | 1.94M | 593K | 1.2M | 1.44M | 1.03M | 1.83M | 1.73M | 1.41M | 991K | 906K | 670K | -6.22M | -6.41M | -6.53M | -6.54M | 43K | 37K | 27K | 15K | 7K |
Shares Outstanding (Basic) | 63.37M | 58.85M | 50.2M | 58.1M | 49.73M | 48.89M | 48.34M | 47.78M | 47.24M | 46.93M | 46.72M | 41.1M | 38.11M | 37.68M | 36.96M | 34.93M | 32.16M | 31.3M | 30.32M | 30.37M | 30.27M | 30.11M |
Shares Outstanding (Diluted) | 63.37M | 58.85M | 50.2M | 56.99M | 49.73M | 48.89M | 48.34M | 47.78M | 47.24M | 46.93M | 46.72M | 41.1M | 38.11M | 37.68M | 37.52M | 34.93M | 32.18M | 31.3M | 30.58M | 30.37M | 30.27M | 30.11M |
EPS (Basic) | -14.55 | -13.61 | -0.48 | -0.85 | -1.21 | -1.61 | -1.85 | -2.07 | -2.34 | -3.76 | -4.02 | -4.30 | -4.75 | -3.65 | -4.02 | -1.15 | -1.68 | -2.29 | -2.80 | -6.11 | -5.42 | -4.90 |
EPS (Diluted) | -14.56 | -13.62 | -0.49 | -0.86 | -1.21 | -1.61 | -1.85 | -2.07 | -2.34 | -3.76 | -4.02 | -4.28 | -4.73 | -3.63 | -4 | -1.15 | -1.68 | -2.29 | -2.80 | -6.11 | -5.42 | -4.90 |
EBITDA | -776.79M | -761.24M | 13.96M | -5.49M | -18.79M | -37.56M | -48.97M | -60.62M | -73.47M | -127.55M | -136.49M | -140.72M | -154.24M | -114.49M | -122.52M | -30.16M | -40.78M | -50.8M | -65.39M | -162.57M | -142.67M | -126.84M |
EBIT | -802.73M | -786.3M | -10.29M | -29.71M | -43.01M | -61.58M | -72.6M | -83.69M | -93.15M | -142.71M | -147.32M | -147.38M | -159.34M | -118.96M | -126.09M | -32.84M | -42.55M | -52.04M | -66.36M | -163.27M | -143.35M | -127.49M |
Depreciation & Amortization | 25.95M | 25.07M | 24.24M | 24.23M | 24.22M | 24.02M | 23.63M | 23.07M | 19.67M | 15.16M | 10.83M | 6.66M | 5.1M | 4.47M | 3.57M | 2.68M | 1.76M | 1.23M | 975K | 703K | 680K | 652K |
Add to Watchlist
Select watchlists to add or remove MIRM